
Scegli la tua etichetta
mostrata direttamente sul flaconcino2 referti di laboratorio
PDF- Testato
- PT-141 5mg
- Laboratorio
- Analiza Białek
- Data
- November 2026
- Risultato
- 99% purity (5.26 mg measured)
- Endotossine
- 4.31 EU/vial
- N. ordine
- Password
PDF- Testato
- PT-141 10mg
- Laboratorio
- Analiza Białek
- Data
- October 2026
- Risultato
- 99% purity (9.14 mg measured)
- Endotossine
- 5.99 EU/vial
- N. ordine
- Password
Testato in modo indipendente, verificabile con la password direttamente presso il laboratorio.
PT-141
Sexual Health
- Testato in laboratorio · 99% di purezza
- Spedito dalla Germania
Ordine
- DHL con tracciamento
- Imballaggio discreto
In sintesi
PT-141 in cifre
I dati chiave dalla nostra enciclopedia.
Voce completa dell'enciclopedia- Class
- Melanocortin agonistbremelanotide
- Form
- Lyophilised powderreconstituted with BAC water
- Sizes
- 5 to 30 mg3 sizes in the shop
What studies show
The source in the lexicon- Kingsberg et al., Obstetrics & Gynecology, 2019
Conoscenze
Tutto su PT-141
Informazioni dettagliate in arrivo.
Dosaggio
Caricamento informazioni sul dosaggio …
Utili da avere
Cosa ti serve insieme
L'acqua batteriostatica viene aggiunta automaticamente al carrello. Siringhe e tamponi con un clic.
Siringhe da insulina
10 pz · 5.50 €
Tamponi imbevuti di alcol
50 pz · 10 €
Quanta acqua?
Unità sulla siringa per la misura del tuo flaconcino.
Apri il calcolatore →Is PT-141 approved?
Yes, as bremelanotide in the USA since 2019. The approval is narrow: women before menopause with acquired, generalised low sexual desire that causes distress. Not for men, not after menopause and according to the label not to enhance sexual performance.
How does PT-141 differ from PDE-5 inhibitors?
The point of action. PDE-5 inhibitors act via blood flow. Bremelanotide activates melanocortin receptors, including MC4R on nerve cells in the brain. How this leads to more desire is not clear according to the label.
What did the phase 3 trials show?
In two trials with 1,267 women in total, desire rose by 0.35 points more than on placebo after 24 weeks and distress fell by 0.33 points more. Both were statistically significant. In the open extension over 52 weeks the values stayed stable.
How long does PT-141 stay in the body?
After one dose under the skin the level peaks after about one hour, the half-life is about 2.7 hours. That fits use on demand, as the entry describes.
Which side effects were seen?
Most often nausea (40 percent versus 1.3 percent on placebo), facial flushing (20 percent) and headache (11 percent). Nausea was the most common reason for stopping. Blood pressure rose by a few mmHg for a short time after a dose.
What about dark patches on the skin?
Via MC1R bremelanotide stimulates pigment formation. Patchy darkening, including on the face and gums, was rare with dosing according to the label (about 1 percent). After up to 16 doses on consecutive days it occurred in more than a third and did not resolve in everyone.
Correlati
Prodotti correlati
PT-141 Nasal
Peptidi · Salute sessuale e abbronzatura Salute sessuale e abbronzatura
1 misura
Oxytocin Acetate
Peptidi · Salute sessuale e abbronzatura Salute sessuale e abbronzatura
3 misure
= da 10 €/fiala
Oxytocin Nasal
Peptidi · Salute sessuale e abbronzatura Salute sessuale e abbronzatura
1 misura
Alprostadil
Peptidi · Salute sessuale e abbronzatura Salute sessuale e abbronzatura
1 misura
= 32 €/fiala
PT-141